GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK Board changes

For media and investors only- Elizabeth (Liz) McKee Anderson to join the Board as Non-Executive Director- Appointment follows announcement that Dr Laurie Glimcher will retire from the B... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
US FDA accepts new drug application for GSK’s momelotinib for the treatment of myelofibrosis

For media and investors only- Regulatory submission included data from the pivotal MOMENTUM phase III clinical trial that met all primary and key secondary efficacy endpointsGSK plc (LS... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
Statement: Zantac (ranitidine) U.S. litigation

For media and investors only- Notice of Voluntary Dismissal to be filed in Bayer case, first scheduled Zantac trial- Plaintiff ongoing litigation inconsistent with scientific consensus,... Read More
GSK
3 years ago ⋅ English ⋅ 2 min read
Newsroom
GSK completes acquisition of Affinivax, Inc.

For media and investors onlyGSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in C... Read More
GSK
3 years ago ⋅ English ⋅ 1 min read
Newsroom
GSK Announces Offer to Repurchase Exchangeable Senior Notes Due 2023

For media and investors onlyGSK plc (LSE/NYSE: GSK) announced today that its wholly owned subsidiary, GSK Finance (No.3) plc, is offering to repurchase for cash any and all of its outst... Read More
GSK
3 years ago ⋅ English ⋅ 9 min read
Newsroom
ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine

For media and investors onlyViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the Medicines Patent Pool (MPP) today... Read More